Literature DB >> 16914635

Implementing guidelines for the institutional use of factor VIIa (recombinant): a multidisciplinary solution.

Celeste N Rudisill1, Rebecca H Hockman, Kathlene A Degregory, Alan H Mutnick, Barbara Gail Macik.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16914635     DOI： 10.2146/ajhp060093

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN： 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  2 in total

1.  Use of Activated Factor VII in Patients with Diffuse Alveolar Hemorrhage: A 10 Years Institutional Experience.

Authors:  Vikas Pathak; Judy Kuhn; Don Gabriel; Jennifer Barrow; J Charles Jennette; David C Henke
Journal:  Lung       Date:  2015-03-24       Impact factor: 2.584

Review 2.  An evaluation of eptacog alfa in nonhaemophiliac conditions.

Authors:  Gordon Mallarkey; Tim Brighton; Amanda Thomson; Karen Kaye; Paul Seale; Madlen Gazarian
Journal:  Drugs       Date:  2008       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.